Epoetin-β: effect on cancer mortality risk insignificant for most

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1286, 2010-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of darbepoetin-α to treat anaemia in patients with cancer is associated with lower overall costs compared with epoetin-α and epoetin-β

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Epoetin-β: Anti-epoetin-antibody-induced PRCA in a child: case report

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Increased mortality with epoetin-α

Reactions Weekly, Vol. 1, Iss. 1146-1147, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Increased mortality with epoetin-α

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer

By Beguin Y.

Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. : 269-282

Adis International

Access to resources Recommend Favorite